Kai Beckmann, CEO of Performance Materials at German giant Merck, stated that Israeli innovation is behind almost half of Merck’s healthcare revenues. Merck has just opened a new technology innovation laboratory at its subsidiary, Qlight Nanotech in Jerusalem.
Half of Merck healthcare revenue is due to Israel
This entry was posted in Economy & Business. Bookmark the permalink.